Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-09-16 Sale |
2021-09-20 5:02 pm |
Magenta Therapeutics Inc. | MGTA | Deardorf Caren Chief Commercial Officer |
6,238 | $6.73 | $41,982 | 13,762 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-07 Option Award |
2024-06-11 4:21 pm |
N/A 2034-06-07 |
Crinetics Pharmaceuticals Inc. | CRNX | Deardorf Caren Director |
15,900 | $0 | 21,900 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 5:00 pm |
N/A 2033-06-15 |
Crinetics Pharmaceuticals Inc. | CRNX | Deardorf Caren Director |
23,500 | $0 | 23,500 (Direct) |
View |
| 2022-11-30 Option Award |
2022-12-02 4:23 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Deardorf Caren Chief Commercial Officer |
3,000 | $0.94 | 19,762 (Direct) |
View |
| 2022-08-01 Option Award |
2022-08-01 9:10 pm |
N/A 2032-07-31 |
Magenta Therapeutics Inc. | MGTA | Deardorf Caren Chief Commercial Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-21 4:45 pm |
N/A 2032-06-16 |
Crinetics Pharmaceuticals Inc. | CRNX | Deardorf Caren Director |
4,375 | $0 | 4,375 (Direct) |
View |
| 2022-05-31 Option Award |
2022-06-06 4:05 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Deardorf Caren Chief Commercial Officer |
3,000 | $0.99 | 16,762 (Direct) |
View |
| 2022-05-17 Option Award |
2022-05-19 4:17 pm |
N/A 2032-05-16 |
Magenta Therapeutics Inc. | MGTA | Deardorf Caren Chief Commercial Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-03-11 Option Award(A) |
2022-04-04 7:09 pm |
N/A 2032-03-10 |
Crinetics Pharmaceuticals Inc. | CRNX | Deardorf Caren Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2022-03-11 Option Award |
2022-03-14 5:25 pm |
N/A 2032-03-10 |
Crinetics Pharmaceuticals Inc. | CRNX | Deardorf Caren Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 5:20 pm |
N/A 2032-02-14 |
Magenta Therapeutics Inc. | MGTA | Deardorf Caren Chief Commercial Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2021-09-14 Option Award |
2021-09-16 7:41 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Deardorf Caren Chief Commercial Officer |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 4:33 pm |
N/A 2031-07-05 |
Magenta Therapeutics Inc. | MGTA | Deardorf Caren Chief Commercial Officer |
200,000 | $0 | 200,000 (Direct) |
View |
Ownership |
2021-07-08 4:32 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Deardorf Caren Chief Commercial Officer |
0 | $0 | 0 (Direct) |
View |